000650 仁和藥業
按盤價 
5.900 -0.030 (-0.506%)
5.900 -0.030 (-0.506%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.054 | 7.922 | 9.669 | 10.418 | 12.814 |
| 總資產報酬率 ROA (%) | 4.865 | 6.457 | 7.524 | 7.900 | 10.018 |
| 投入資產回報率 ROIC (%) | 5.802 | 7.768 | 9.272 | 9.899 | 12.388 | 邊際利潤分析 |
| 銷售毛利率 (%) | 36.426 | 37.940 | 37.122 | 36.617 | 37.975 |
| 營業利潤率 (%) | 21.775 | 19.019 | 17.858 | 18.498 | 21.008 |
| 息稅前利潤/營業總收入 (%) | 21.768 | 18.756 | 17.367 | 18.056 | 19.838 |
| 淨利潤/營業總收入 (%) | 16.556 | 13.904 | 12.508 | 13.808 | 16.206 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 80.443 | 92.002 | 109.815 | 99.102 | 95.101 |
| 價值變動淨收益/利潤總額(%) | 6.088 | 11.455 | 8.465 | 7.176 | 3.040 |
| 營業外收支淨額/利潤總額(%) | -0.151 | -0.047 | 0.025 | 0.029 | -0.243 | 償債能力分析 |
| 流動比率 (X) | 5.096 | 7.574 | 6.103 | 3.934 | 4.187 |
| 速動比率 (X) | 4.706 | 6.809 | 5.509 | 3.541 | 3.566 |
| 資產負債率 (%) | 13.084 | 9.041 | 10.614 | 15.888 | 14.201 |
| 帶息債務/全部投入資本 (%) | 5.860 | 1.107 | 1.513 | 5.261 | 3.552 |
| 股東權益/帶息債務 (%) | 1,597.707 | 8,878.107 | 6,466.067 | 1,785.763 | 2,708.751 |
| 股東權益/負債合計 (%) | 599.079 | 912.619 | 758.439 | 473.282 | 538.965 |
| 利息保障倍數 (X) | 837.840 | -74.116 | -35.063 | -40.342 | -17.724 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 45.690 | 33.929 | 26.850 | 26.590 | 26.496 |
| 存貨周轉天數 (天) | 66.450 | 66.446 | 51.445 | 58.365 | 62.718 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 17/03/2026 14:59 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
